Jublia Toenail Treatment: Read the Cure Rates and Timeline

For prescription toenail treatment during GLP-1 care, ask which outcome a success rate describes. Jublia studies measured negative fungal tests and complete cure separately.

Read both parts of complete cure

The U.S. label, revised July 2025, defines mycologic cure as a negative fungal culture and negative potassium hydroxide (KOH) examination. Complete cure also required no visible clinical involvement of the target toenail. [1]

In trial 1, complete cure occurred in 17.8% with Jublia versus 3.3% with vehicle; mycologic cure occurred in 55.2% versus 16.8%. Trial 2 reported 15.2% versus 5.5%, and 53.4% versus 16.9%, respectively. [1] Read the outcome name beside each percentage rather than selecting the largest number.

A useful consultation sentence is: “When you say this treatment works, do you mean negative tests, a nail without visible infection, or another result?” Ask how your own progress would be assessed and what would trigger a review of the plan.

Keep the study population and timetable attached

The trials enrolled adults aged 18–70 with 20–50% target-nail involvement, excluding certain fungal masses and nail-matrix involvement. Treatment lasted 48 weeks; cure was assessed at week 52, four weeks later. [1]

Those details limit what the percentages can promise for a nail with a different extent of disease. They also give you a question about timing: when should the prescriber assess progress, and how will they distinguish a slow change from a reason to reconsider treatment?

Bring any date driving your cosmetic plans, such as a holiday, wedding or pedicure appointment. State the date as a preference to discuss, not as a deadline the nail must meet. These trials do not establish a different response in GLP-1 users or show that a GLP-1 medicine caused the nail change.

What FDA said about an advertising claim

In a September 9, 2025 untitled letter to Bausch, FDA found a Jublia television advertisement misleading because its portrayal implied complete cure for all patients and immediate results. The agency said the advertised impression was unsupported by the trial findings; an on-screen treatment-duration disclaimer did not correct it. [2]

This is a dated regulatory finding about that advertisement. It is not a claim that the medicine never helps. When evaluating a treatment pitch, keep the visual promise, the written outcome definition and the stated follow-up period together.

Confirm that the nail problem is fungal

The American Academy of Dermatology (AAD) says injury and nail psoriasis can resemble fungal infection. A dermatologist may examine a nail sample under a microscope to help confirm the diagnosis and select treatment. Its guidance distinguishes clearing infection from restoring the nail when possible, and notes that nails grow slowly. [3]

Ask what established your diagnosis, which nail will be followed and whether previous treatment affects the next assessment. If you have not had the change examined, our lifted and discolored nail guide is a starting point for that appointment.

Discuss cosmetic products and irritation

The label says cosmetic nail products' effects on efficacy have not been evaluated. It warns of flammability, irritation, blisters and pain. [1]

AAD advises asking your dermatologist about polish during fungal treatment. [3] Bring the names of any polish, gel, acrylic or home nail product you want to use. Ask the prescriber or pharmacist how the written instructions apply to your routine, including what to do if the treated area stays irritated.

Ask for an explanation before changing treatment because a photograph looks disappointing or a laboratory result has improved. Follow the treating clinician's plan; this article does not select a medicine, set your treatment duration or promise a clear nail by a particular date.

Printed book

How to Keep Your Face on GLP-1

$12.95 + free shipping

Order Now

✓ 30 day money back guarantee

This article provides general education, not a diagnosis or an individual treatment plan. Medication information refers to US sources. Discuss medication, nutrition and cosmetic treatment decisions with qualified clinicians.